Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer

Abstract

Together, our results screened several IRGs of clinical significance, revealed drivers of the immune repertoire, and demonstrated the importance of a personalized, IRG-based immune signature in the recognition, surveillance, and prognosis of PTC.